-
1
المؤلفون: Zaid, Syed, Avvedimento, Marisa, Vitanova, Keti, Akansel, Serdar, Bhadra, Oliver, Ascione, Guido, Saha, Shekhar, Noack, Thilo, Tagliari, Ana Paula, Pizano, Alejandro, Donatelle, Marissa, Squiers, John, Goel, Kashish, Leurent, Guillaume, Asgar, Anita, Ruaengsri, Chawannuch, Wang, Lin, Leroux, Lionel, Flagiello, Michele, Algadheeb, Muhanad, Werner, Paul, Ghattas, Angie, Bartorelli, Antonio, Dumonteil, Nicholas, Geirsson, Arnar, van Belle, Eric, Massi, Francesco, Wyler von Ballmoos, Moritz, Goel, Sachin, Reardon, Michael, Bapat, Vinayak, Nazif, Tamim, Kaneko, Tsuyoshi, Modine, Thomas, Denti, Paolo, Tang, Gilbert, Tang, Gilbert H.L.
المساهمون: Houston Methodist Hospital [Houston, TX, USA], Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], CHU Bordeaux [Bordeaux], Hospices Civils de Lyon (HCL), Clinique Pasteur, Clinique Pasteur [Toulouse], CHU Lille, Mount Sinai Health System, Dr Bhadra has received travel compensation from Edwards Lifesciences. Dr Tagliari has received research support from the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior. Dr Leurent has been a consultant and physician proctor for and has received speaker honoraria from Abbott. Dr Asgar has been a consultant for Medtronic, Abbott, Edwards Lifesciences, and W. L. Gore & Associates, and has received research grants from Abbott. Dr Leroux has been a physician proctor for Medtronic and Abbott, and a consultant for Edwards Lifesciences. Dr Dumonteil has received speaker honoraria and travel reimbursement by Edwards Lifesciences, and has been a physician proctor and consultant for Edwards Lifesciences. Dr Geirsson has been a member of the Medtronic Strategic Surgical Advisory Board. Dr Wyler von Ballmoos has served as a consultant for LivaNova, Medtronic, and Boston Scientific. Dr Reardon has been a consultant for Medtronic, Boston Scientific, Abbott, and W. L. Gore & Associates. Dr Bapat has served as a consultant for Medtronic, Edwards Lifesciences, 4C Medical, and Boston Scientific. Dr Nazif has equity in Venus Medtech, and has received consulting fees or honoraria from Keystone Heart, Edwards Lifesciences, Medtronic, and Boston Scientific. Dr Kaneko has been a speaker for Edwards Lifesciences, Medtronic, Abbott, and Baylis Medical, and has been a consultant for 4C Medical. Dr Modine has been a physician proctor and consultant for Medtronic, Edwards Lifesciences, and Abbott. Dr Denti has received speaker honoraria from Abbott and Edwards Lifesciences, and has been a consultant for InnovHeart. Dr Tang has been a physician proctor for Medtronic, a consultant for Medtronic, Abbott, and NeoChord, and a physician advisory board member for Abbott, Boston Scientific and JenaValve, and has received speaker honoraria from Siemens Healthineers and East End Medical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
المصدر: JACC: Cardiovascular Interventions
JACC: Cardiovascular Interventions, 2023, 16 (10), pp.1176-1188. ⟨10.1016/j.jcin.2023.02.029⟩مصطلحات موضوعية: MESH: Aged, MESH: Mitral Valve Insufficiency, MESH: Humans, MESH: Middle Aged, MESH: Registries, transcatheter edge-to-edge repair, MESH: Retrospective Studies, MESH: Mitral Valve, mitral valve replacement, mitral valve repair, MESH: Aged, 80 and over, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Cardiology and Cardiovascular Medicine, mitral valve surgery, MESH: Treatment Outcome
-
2
المؤلفون: Rogers, Jason, Asch, Federico, Sorajja, Paul, Mahoney, Paul, Price, Matthew, Maisano, Francesco, Denti, Paolo, Morse, Michael, Rinaldi, Michael, Bedogni, Francesco, de Marco, Federico, Rollefson, William, Chehab, Bassem, Williams, Mathew, Leurent, Guillaume, Morikawa, Takao, Asgar, Anita, Rodriguez, Evelio, von Bardeleben, Ralph Stephan, Kar, Saibal
المساهمون: University of California [Davis] (UC Davis), University of California (UC), Scripps Clinic [San Diego, CA, USA], CHU Pontchaillou [Rennes], Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), University Medical Center [Mainz], Los Robles Regional Medical Center [California], The EXPAND G4 study was funded and sponsored by Abbott. Dr Rogers has received institutional research funding from Abbott and Boston Scientific, and has received consulting fees from Abbott, Baylis, and Boston Scientific. Dr Asch’s work as director of an academic core laboratory is through institutional research grants (MedStar Health) with Abbott, Boston Scientific, Medtronic, Edwards Lifesciences, Neovasc, Ancora Heart, LivaNova, MVRx, InnovHeart, Polares Medical, and Aria CV. Dr Sorajja has received consulting fees from Abbott, Medtronic, Boston Scientific, vDyne, TriFlo, W.L. Gore & Associates, Anteris, Evolution Medical, Half Moon Medical, Neovasc, TeleFlex, and Shifamed, and has received grant support from Abbott, VDyne, Medtronic, and Highlife. Dr Mahoney serves as a consultant and proctor for Medtronic, Edwards Lifesciences, and Boston Scientific, is a consultant for Abbott, and has received research support from Edwards Lifesciences, Medtronic, Abbott, and Boston Scientific. Prof Maisano has received grant and/or institutional research support from Abbott, Medtronic, Edwards Lifesciences, Biotronik, Boston Scientific, NVT, and Terumo, has received consulting fees, honoraria (personal and institutional) from Abbott, Medtronic, Edwards Lifesciences, Xeltis, and Cardiovalve, has received royalty income and intellectual property rights from Edwards Lifesciences, and is a shareholder (including share options) in CardioGard, Magenta, SwissVortex, Transseptal Solutions, Occlufit, 4Tech, and Perifect. Dr Denti has received consulting and speaker fees from Abbott. Dr Morse is a consultant for Edwards Lifesciences. Dr Rinaldi has served on the advisory board for Boston Scientific, has taught courses for Abbott and Edwards Lifesciences, has served as a consultant for Abbott, Boston Scientific, and Edwards Lifesciences, has received research and grant support from Boston Scientific, and has served as a proctor for Abbott and Edwards Lifesciences. Dr Bedogni has received consulting and speaker fees from Abbott. Dr De Marco is a consultant and has provided paid expert testimony for Abbott and Boston Scientific. Dr Chehab has received study grants and consulting fees from Abbott, Edwards Lifesciences, and BioTronics. Dr Price has received consulting fees from ACIST, Medtronic, Biotronik, Boston Scientific, Abbott, Philips, InnovHeart, Shockwave, and W.L. Gore & Associates (outside the submitted work). Dr Williams has received research funding from Abbott, Medtronic, Boston Scientific, and Edwards Lifesciences. Dr Leurent has received proctoring, lecture, and consulting fees from Abbott. Dr Morikawa has received speaking, consulting, and proctoring fees from Abbott. Dr Asgar is a consultant for and has received research support from Abbott. Dr Rodriguez has received consulting fees from Abbott, AtriCure, Boston Scientific, Edwards Lifesciences, NeoChord, and Philips. Prof von Bardeleben has served in unpaid trial activities for Abbott, Edwards Lifesciences, Medtronic, and the University of Gottingen (IIT), and is an advisory board or Speakers Bureau member for Abbott Cardiovascular, Edwards Lifesciences, Medtronic, and NeoChord. Dr Kar has received consulting fees from Abbott, Boston Scientific, Medtronic, and W.L. Gore & Associates, and has received grant support from Edwards Lifesciences and V-Wave. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
المصدر: JACC: Cardiovascular Interventions
JACC: Cardiovascular Interventions, 2023, 16 (12), pp.1474-1485. ⟨10.1016/j.jcin.2023.05.014⟩مصطلحات موضوعية: MESH: Mitral Valve Insufficiency, MESH: Humans, transcatheter edge-to-edge repair, MESH: Quality of Life, MESH: Reactive Oxygen Species, MitraClip system, MESH: Prospective Studies, mitral valve repair, MESH: Constriction, Pathologic, MESH: Cardiomyopathies, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, mitral regurgitation, TEER, MESH: Treatment Outcome
-
3
المؤلفون: Christian de Place, Erwan Donal, Renaud Gervais, Jean-Claude Daubert, Christophe Leclercq, Gaelle Kervio, Fabrice Bauer, Philippe Mabo
المساهمون: Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de cardiologie et maladies vasculaires [Rennes] = Cardiac, Thoracic, and Vascular Surgery [Rennes], CHU Pontchaillou [Rennes], CIC-IT Rennes, Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de cardiologie [CHU Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)
المصدر: European Journal of Echocardiography
European Journal of Echocardiography, Oxford University Press (OUP), 2009, 10 (1), pp.133-8. ⟨10.1093/ejechocard/jen188⟩
European Journal of Echocardiography, 2009, 10 (1), pp.133-8. ⟨10.1093/ejechocard/jen188⟩مصطلحات موضوعية: Male, MESH: Mitral Valve Insufficiency, MESH: Myocardial Contraction, Cardiomyopathy, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, MESH: Observer Variation, MESH: Risk Assessment, Severity of Illness Index, MESH: Stroke Volume, MESH: Ultrasonography, Doppler, Pulsed, MESH: Linear Models, 0302 clinical medicine, [INFO.INFO-TS]Computer Science [cs]/Signal and Image Processing, Mitral valve, Prospective Studies, 030212 general & internal medicine, Observer Variation, Myocardial strain imaging, Ejection fraction, Ventricular Remodeling, Mitral Valve Insufficiency, MESH: Heart Failure, Systolic, Dilated cardiomyopathy, General Medicine, Prognosis, MESH: Reproducibility of Results, medicine.anatomical_structure, Ultrasonography, Doppler, Pulsed, MESH: Survival Analysis, cardiovascular system, Cardiology, Female, [SDV.IB]Life Sciences [q-bio]/Bioengineering, Cardiology and Cardiovascular Medicine, [SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing, Cardiomyopathy, Dilated, medicine.medical_specialty, Ventricular dyssynchrony, Heart failure, MESH: Ventricular Remodeling, Risk Assessment, MESH: Prognosis, MESH: Multivariate Analysis, Contractility, 03 medical and health sciences, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, MESH: Severity of Illness Index, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, cardiovascular diseases, MESH: Cardiomyopathy, Dilated, MESH: Kaplan-Meier Estimate, Mitral regurgitation, MESH: Humans, business.industry, Reproducibility of Results, Stroke Volume, medicine.disease, Myocardial Contraction, Survival Analysis, MESH: Prospective Studies, MESH: Male, Ventricle, Multivariate Analysis, Linear Models, Feasibility Studies, MESH: Feasibility Studies, business, MESH: Female, Heart Failure, Systolic
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::671a5da3f4b8dcbfe71ba719ef6ea3c0
https://doi.org/10.1093/ejechocard/jen188 -
4
المؤلفون: David Attias, Philippe Gabriel Steg, Franck Iserin, Daniel Sidi, Mireille Claustres, Laurence Faivre, Marlène Rio, Marie-Ange Delrue, Philippe Ravaud, Catherine Boileau, Carine Roy, Christine Francannet, Henri Plauchu, Sylvie Odent, Christophe Béroud, Guillaume Jondeau, Martine Le Merrer, Chantal Stheneur, Gwenaëlle Collod-Béroud, Stanislas Lyonnet, Philippe Khau Van Kien, Annick Rossi, Laurence Cohen, Didier Lacombe, Delphine Detaint
المساهمون: Consultation Marfan, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Bichat, Service de cardiologie, Université Paris Diderot - Paris 7 (UPD7)-AP-HP - Hôpital Bichat - Claude Bernard [Paris]-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Génétique et épigénétique des maladies métaboliques, neurosensorielles et du développement (Inserm U781), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de pédiatrie, urgences enfants [CHU Ambroise-Paré], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Ambroise Paré [AP-HP], Modèles et méthodes de l'évaluation thérapeutique des maladies chroniques, Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Département d'épidémiologie, biostatistique et recherche clinique, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Laboratoire de génétique des maladies rares. Pathologie moleculaire, etudes fonctionnelles et banque de données génétiques (LGMR), Université Montpellier 1 (UM1)-IFR3, Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre de génétique - Centre de référence des maladies rares, anomalies du développement et syndromes malformatifs (CHU de Dijon), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Service de génétique médicale, Université de Bordeaux (UB)-CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin, Unité de Cardiologie Pédiatrique, Hôpital Privé Jacques Cartier [Massy], Unité de Génétique Médicale, Hôtel-Dieu-CHU Clermont-Ferrand-Université d'Auvergne - Clermont-Ferrand I (UdA), Service de cardiologie pédiatrique [CHU Necker], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Necker - Enfants Malades [AP-HP], Service de Génétique Médicale [CHU Necker], Service de Génétique Clinique, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Sud, Service de Génétique, Hôpital de l'Hôtel Dieu [CHU-HCL], Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, Service de génétique [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Hémostase, bio-ingénierie et remodelage cardiovasculaires (LBPC), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Institut Galilée-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de biochimie, d'hormonologie et de génétique moléculaire [CHU Amrboise Paré], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris]-Université Paris Diderot - Paris 7 (UPD7), Service de pédiatrie, urgences enfants [Ambroise-Paré], Hôpital Ambroise Paré [AP-HP]-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), CHU Necker - Enfants Malades [AP-HP]-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Université Paris Diderot - Paris 7 (UPD7)-Université Paris 13 (UP13)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Galilée, Service de biochimie, d'hormonologie et de génétique moléculaire [Amrboise Paré], Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Ambroise Paré [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bichat, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Ambroise Paré [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Laboratoire de Recherche Magellan, Université Jean Moulin - Lyon 3 (UJML), Université de Lyon-Université de Lyon-Institut d'Administration des Entreprises (IAE) - Lyon, Service de Génétique Médicale [CHU Clermont-Ferrand], CHU Estaing [Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand, Institut de génétique humaine (IGH), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Necker - Enfants Malades [AP-HP], CHU Necker - Enfants Malades [AP-HP], Unité de génétique médicale, hôpital Sud, Hôpital Bichat - Claude Bernard, Modèles et méthodes de l'évaluation thérapeutique des maladies chroniques (U738 / UMR_S738), Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Bichat, Assistance publique - Hôpitaux de Paris (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris]-Université Paris Diderot - Paris 7 ( UPD7 ), Génétique et épigénétique des maladies métaboliques, neurosensorielles et du développement ( Inserm U781 ), Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Service de pédiatrie, urgences enfants, Université de Versailles Saint-Quentin-en-Yvelines ( UVSQ ) -Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Ambroise Paré, Université Paris Diderot - Paris 7 ( UPD7 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Assistance publique - Hôpitaux de Paris (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Laboratoire de génétique des maladies rares. Pathologie moleculaire, etudes fonctionnelles et banque de données génétiques, Université Montpellier 1 ( UM1 ) -IFR3-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université de Montpellier ( UM ), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand ( CHU Dijon ), Université de Bordeaux ( UB ) -CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin, Hôtel-Dieu-CHU Clermont-Ferrand-Université d'Auvergne - Clermont-Ferrand I ( UdA ), Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Necker - Enfants Malades [AP-HP], Université de Rennes 1 ( UR1 ), Université de Rennes ( UNIV-RENNES ) -Université de Rennes ( UNIV-RENNES ) -Hôpital Sud, Université Claude Bernard Lyon 1 ( UCBL ), Université de Lyon-Université de Lyon-Hôtel Dieu, CHU Rouen-Université de Rouen Normandie ( UNIROUEN ), Normandie Université ( NU ) -Normandie Université ( NU ), Hémostase, bio-ingénierie et remodelage cardiovasculaires ( LBPC ), Université Paris 13 ( UP13 ) -Université Paris Diderot - Paris 7 ( UPD7 ) -Université Sorbonne Paris Cité ( USPC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Institut Galilée, Service de biochimie, d'hormonologie et de génétique moléculaire, IFR3, Université Montpellier 1 (UM1)-Université Montpellier 1 (UM1)-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris Diderot - Paris 7 (UPD7)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de Recherche Magellan, Institut d'Administration des Entreprises (IAE) - Lyon-Université Jean Moulin - Lyon 3 (UJML), Université de Lyon-Université de Lyon, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Diderot - Paris 7 (UPD7), COLLOD-BEROUD, Gwenaëlle
المصدر: Circulation
Circulation, American Heart Association, 2009, 120 (25), pp.2541-9. ⟨10.1161/CIRCULATIONAHA.109.887042⟩
Circulation, 2009, 120 (25), pp.2541-2549. ⟨10.1161/CIRCULATIONAHA.109.887042⟩
Circulation, American Heart Association, 2009, 120 (25), pp.2541-9. 〈10.1161/CIRCULATIONAHA.109.887042〉
Circulation, American Heart Association, 2009, 120 (25), pp.2541-2549. ⟨10.1161/CIRCULATIONAHA.109.887042⟩مصطلحات موضوعية: Male, MESH : Receptors, Transforming Growth Factor beta, MESH : Mitral Valve Prolapse, Gene mutation, Gastroenterology, Marfan Syndrome, 0302 clinical medicine, MESH: Pregnancy, MESH : Child, Pregnancy, Mitral valve, MESH: Child, Medicine, MESH: Incidence, Child, MESH: Aneurysm, Dissecting, Aortic dissection, 0303 health sciences, Mitral Valve Prolapse, MESH: Middle Aged, Incidence, Prognosis, MESH: Case-Control Studies, MESH : Incidence, Aortic Aneurysm, 3. Good health, Survival Rate, MESH : Phenotype, MESH: Young Adult, Cardiology and Cardiovascular Medicine, musculoskeletal diseases, MESH : Case-Control Studies, medicine.medical_specialty, MESH : Young Adult, MESH : Cohort Studies, Fibrillins, MESH: Phenotype, Sudden death, MESH: Prognosis, MESH: Protein-Serine-Threonine Kinases, 03 medical and health sciences, MESH: Mitral Valve Prolapse, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, MESH : Adolescent, Physiology (medical), Humans, MESH : Middle Aged, MESH : Aneurysm, Dissecting, MESH: Adolescent, [SDV.GEN]Life Sciences [q-bio]/Genetics, MESH: Humans, MESH : Humans, Receptor, Transforming Growth Factor-beta Type II, Case-control study, [SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology, MESH: Adult, medicine.disease, MESH: Aortic Aneurysm, MESH : Pregnancy, MESH : Mitral Valve Insufficiency, Case-Control Studies, Mutation, [ SDV.GEN ] Life Sciences [q-bio]/Genetics, Receptors, Transforming Growth Factor beta, MESH: Female, Marfan syndrome, MESH: Mitral Valve Insufficiency, Fibrillin-1, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, [SDV.BBM.BM] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology, Cohort Studies, MESH : Female, MESH: Kaplan-Meiers Estimate, MESH: Cohort Studies, MESH : Prognosis, Incidence (epidemiology), Microfilament Proteins, Mitral Valve Insufficiency, MESH : Adult, [ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Middle Aged, MESH : Survival Rate, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, MESH : Aortic Aneurysm, Phenotype, medicine.anatomical_structure, Female, MESH: Receptors, Transforming Growth Factor beta, MESH : Mutation, MESH : Protein-Serine-Threonine Kinases, Adult, MESH: Mutation, MESH : Microfilament Proteins, Adolescent, MESH: Survival Rate, MESH : Male, [SDV.GEN.GH] Life Sciences [q-bio]/Genetics/Human genetics, Protein Serine-Threonine Kinases, MESH: Marfan Syndrome, Young Adult, MESH: Microfilament Proteins, Internal medicine, Survival rate, 030304 developmental biology, MESH : Marfan Syndrome, business.industry, MESH : Kaplan-Meiers Estimate, MESH: Male, Surgery, Aortic Dissection, [SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics, business
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a333b7759c48f84cb319e91c2bb0d504
https://www.hal.inserm.fr/inserm-00440947 -
5
المؤلفون: Philippe, Nicot, Irène, Frachon, Catherine, Hill
المساهمون: Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Département de Médecine Interne et Pneumologie [Brest] (DMIP - Brest), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Institut Gustave Roussy (IGR)
المصدر: La Presse medicale
La Presse medicale, Paris, Masson et Cie, 2013, 42 (4 Pt 1), pp.411-8. ⟨10.1016/j.lpm.2013.02.310⟩مصطلحات موضوعية: MESH: Mitral Valve Insufficiency, MESH: Expert Testimony, Drug Industry, MESH: Probability, [SDV]Life Sciences [q-bio], Aortic Valve Insufficiency, Eligibility Determination, MESH: Causality, MESH: Fenfluramine, Diagnosis, Differential, MESH: Cross-Sectional Studies, MESH: Eligibility Determination, Risk Factors, MESH: Appetite Depressants, MESH: Risk Factors, MESH: Diagnosis, Differential, Appetite Depressants, Fenfluramine, Drugs, Generic, Humans, Expert Testimony, MESH: Drugs, Generic, Probability, MESH: Humans, MESH: Compensation and Redress, Mitral Valve Insufficiency, MESH: Aortic Valve Insufficiency, Causality, MESH: France, Cross-Sectional Studies, MESH: Drug Industry, Compensation and Redress, France
URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ebc8a6a7a6ef4ef74b6a4ab69d4be3dd
https://hal.univ-brest.fr/hal-00935392 -
6
المؤلفون: Sylvestre Maréchaux, Dan Rusinaru, Pierre-Vladimir Ennezat, Yannick Jobic, Jacques Boulanger, Christophe Tribouilloy, Elise Arnalsteen, Patricia Reant, Stéphane Ederhy, Thierry Garban, Erwan Donal, Antoine Jeu
المساهمون: Pôle cardiovasculaire et thoracique, CHU Amiens-Picardie, Mécanismes physiologiques et conséquences des calcifications cardiovasculaires: rôle des remodelages cardiovasculaires et osseux, Université de Picardie Jules Verne (UPJV)-Institut National de la Santé et de la Recherche Médicale (INSERM), Groupement Hospitalier de l'Institut Catholique de Lille, Faculté Libre de Médecine de Lille (FLM), Institut Catholique de Lille (ICL), Université catholique de Lille (UCL)-Université catholique de Lille (UCL)-Institut Catholique de Lille (ICL), Université catholique de Lille (UCL)-Université catholique de Lille (UCL)-UC Lille, CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Département de cardiologie, CHU Bordeaux [Bordeaux]-Hôpital Haut-Lévêque [CHU Bordeaux], CHU Bordeaux [Bordeaux], Service de Médecine Interne et Cardiologie, Centre Hospitalier de Beauvais, Service de Cardiologie, Centre Hospitalier de Compiègne, Service de cardiologie, Hôpital Cardiologique-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Hôpital Universitaire G et R Laennec, Département de Cardiologie (CHRU - Cardio), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Faculté Libre de Médecine-UC Lille, Service de Cardiologie [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)
المصدر: Circulation
Circulation, 2012, 126 (24), pp.2852-8. ⟨10.1161/CIRCULATIONAHA.112.111260⟩
Circulation, American Heart Association, 2012, 126 (24), pp.2852-8. ⟨10.1161/CIRCULATIONAHA.112.111260⟩مصطلحات موضوعية: MESH: Mitral Valve Insufficiency, Male, 030204 cardiovascular system & hematology, drugs, MESH: Fenfluramine, Coronary artery disease, chemistry.chemical_compound, MESH: Safety-Based Drug Withdrawals, 0302 clinical medicine, [INFO.INFO-TS]Computer Science [cs]/Signal and Image Processing, MESH: Risk Factors, MESH: Appetite Depressants, Risk Factors, Single-Blind Method, 030212 general & internal medicine, Prospective Studies, MESH: Aged, 2. Zero hunger, Benfluorex, MESH: Middle Aged, Mitral Valve Insufficiency, regurgitation, MESH: Aortic Valve Insufficiency, MESH: Follow-Up Studies, Middle Aged, 3. Good health, Europe, medicine.anatomical_structure, Echocardiography, Cardiology, [SDV.IB]Life Sciences [q-bio]/Bioengineering, Female, Cardiology and Cardiovascular Medicine, [SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing, medicine.medical_specialty, MESH: Diabetes Mellitus, Aortic Valve Insufficiency, valves, 03 medical and health sciences, Safety-Based Drug Withdrawals, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Physiology (medical), Internal medicine, Diabetes mellitus, Appetite Depressants, Fenfluramine, medicine, Diabetes Mellitus, Product Surveillance, Postmarketing, Humans, MESH: Product Surveillance, Postmarketing, Heart valve, Aged, MESH: Humans, business.industry, MESH: Single-Blind Method, medicine.disease, MESH: Male, MESH: Prospective Studies, chemistry, Propensity score matching, MESH: Echocardiography, Observational study, MESH: Europe, business, MESH: Female, Body mass index, Dyslipidemia, Follow-Up Studies
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ac9f4cdeaca5ff16810086601b3e921
https://pubmed.ncbi.nlm.nih.gov/23143159 -
7
المؤلفون: Alain Leguerrier, Anne Brunet, Hervé Corbineau, Christophe Thebault, Erwan Donal, M. Laurent, Philippe Mabo, Sophie Mascle
المساهمون: Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de cardiologie et maladies vasculaires [Rennes] = Cardiac, Thoracic, and Vascular Surgery [Rennes], CHU Pontchaillou [Rennes], CIC-IT Rennes, Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de chirurgie thoracique cardiaque et vasculaire [Rennes] = Thoracic and Cardiovascular Surgery [Rennes], Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)
المصدر: European Heart Journal-Cardiovascular Imaging
European Heart Journal-Cardiovascular Imaging, 2012, 13 (11), pp.922-30. ⟨10.1093/ehjci/jes068⟩
European Heart Journal-Cardiovascular Imaging, Oxford UP, 2012, 13 (11), pp.922-30. ⟨10.1093/ehjci/jes068⟩مصطلحات موضوعية: Male, Global longitudinal strain, MESH: Mitral Valve Insufficiency, Time Factors, Statistics as Topic, Hemodynamics, 030204 cardiovascular system & hematology, MESH: Stroke Volume, Ventricular Function, Left, MESH: Ventricular Function, Left, Coronary artery disease, 0302 clinical medicine, Postoperative Complications, MESH: Postoperative Complications, Health Status Indicators, 030212 general & internal medicine, Prospective Studies, Prospective cohort study, Ejection fraction, MESH: Middle Aged, Left ventricular function, Mitral Valve Insufficiency, General Medicine, Stroke volume, Middle Aged, Prognosis, MESH: Predictive Value of Tests, Predictive value of tests, Cardiology, Disease Progression, cardiovascular system, Female, MESH: Disease Progression, [SDV.IB]Life Sciences [q-bio]/Bioengineering, Cardiology and Cardiovascular Medicine, medicine.medical_specialty, MESH: Hemodynamics, Preoperative care, MESH: Prognosis, 03 medical and health sciences, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Predictive Value of Tests, Internal medicine, MESH: Health Status Indicators, medicine, Humans, Radiology, Nuclear Medicine and imaging, cardiovascular diseases, MESH: Statistics as Topic, Mitral regurgitation, MESH: Humans, business.industry, MESH: Time Factors, Stroke Volume, Ultrasonography, Doppler, medicine.disease, MESH: Prospective Studies, MESH: Male, Exercise Test, MESH: Ultrasonography, Doppler, Exercise stress echocardiography, business, MESH: Exercise Test, MESH: Female
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e97ef6396eb9a12f2fdaa805c127c363
https://hal.science/hal-00904242 -
8
المؤلفون: Christophe Thebault, Erwan Donal, M. Laurent, Stéphanie Hamonic, Hervé Corbineau, Alain Leguerrier, David Veillard, Sophie Mascle, Philippe Mabo, Frédéric Schnell
المساهمون: Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de cardiologie et maladies vasculaires [Rennes] = Cardiac, Thoracic, and Vascular Surgery [Rennes], CHU Pontchaillou [Rennes], CIC-IT Rennes, Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de chirurgie thoracique cardiaque et vasculaire [Rennes] = Thoracic and Cardiovascular Surgery [Rennes], Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)
المصدر: Journal of The American Society of Echocardiography
Journal of The American Society of Echocardiography, Elsevier, 2012, 25 (7), pp.766-72. ⟨10.1016/j.echo.2012.04.009⟩
Journal of The American Society of Echocardiography, 2012, 25 (7), pp.766-72. ⟨10.1016/j.echo.2012.04.009⟩مصطلحات موضوعية: Male, Global longitudinal strain, MESH: Mitral Valve Insufficiency, Longitudinal strain, 030204 cardiovascular system & hematology, MESH: Elasticity Imaging Techniques, Ventricular Dysfunction, Left, 0302 clinical medicine, MESH: Ventricular Dysfunction, Left, Medicine, 030212 general & internal medicine, MESH: Treatment Outcome, education.field_of_study, Ejection fraction, MESH: Middle Aged, Left ventricular function, Mitral Valve Insufficiency, Middle Aged, Prognosis, Predictive value, MESH: Reproducibility of Results, Treatment Outcome, Cardiology, Elasticity Imaging Techniques, Female, [SDV.IB]Life Sciences [q-bio]/Bioengineering, Cardiology and Cardiovascular Medicine, medicine.medical_specialty, Population, Sensitivity and Specificity, MESH: Prognosis, 03 medical and health sciences, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, Lv dysfunction, Elastic Modulus, Humans, Radiology, Nuclear Medicine and imaging, education, Mitral regurgitation, MESH: Humans, business.industry, Reproducibility of Results, Mean age, MESH: Male, MESH: Sensitivity and Specificity, Surgery, MESH: Elastic Modulus, business, MESH: Female, Mitral valve surgery
-
9
المساهمون: Département de Cardiologie (CHRU - Cardio), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Mécanismes physiologiques et conséquences des calcifications cardiovasculaires: rôle des remodelages cardiovasculaires et osseux, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Picardie Jules Verne (UPJV), Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Département de Médecine Interne et Pneumologie [Brest] (DMIP - Brest)
المصدر: La Presse medicale
La Presse medicale, Paris, Masson et Cie, 2012, 41 (3 Pt 1), pp.326-7. ⟨10.1016/j.lpm.2012.01.002⟩مصطلحات موضوعية: MESH: Mitral Valve Insufficiency, MESH: Humans, MESH: Appetite Depressants, [SDV]Life Sciences [q-bio], MESH: Norfenfluramine, MESH: Aortic Valve Insufficiency, MESH: Female, ComputingMilieux_MISCELLANEOUS, MESH: Male, MESH: Fenfluramine
URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4534d8c7dee463e712e91ad77e7b169c
https://hal.univ-brest.fr/hal-00932124 -
10
المساهمون: Université Claude Bernard Lyon 1 (UCBL), Université de Lyon
المصدر: Journal of Cardiovascular Medicine
Journal of Cardiovascular Medicine, Lippincott, Williams & Wilkins, 2012, 13 (3), pp.216-221. ⟨10.2459/JCM.0b013e32833daf81⟩مصطلحات موضوعية: MESH: Mitral Valve Insufficiency, medicine.medical_specialty, Acute coronary syndrome, [SDV]Life Sciences [q-bio], MESH: Echocardiography, Transesophageal, 030204 cardiovascular system & hematology, MESH: Magnetic Resonance Imaging, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, MESH: Anti-Bacterial Agents, MESH: Gram-Negative Bacterial Infections, Medicine, Endocarditis, 030212 general & internal medicine, MESH: Endocarditis, Bacterial, ComputingMilieux_MISCELLANEOUS, MESH: Treatment Outcome, MESH: Humans, MESH: Middle Aged, biology, business.industry, General Medicine, MESH: Dental Caries, medicine.disease, biology.organism_classification, MESH: Acute Coronary Syndrome, MESH: Male, MESH: Coronary Angiography, MESH: Cardiobacterium, Cardiology, MESH: Cardiovascular Agents, Cardiology and Cardiovascular Medicine, business, Cardiobacterium hominis, MESH: Embolism
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcfc822c076b391d50ec7d151126ffad
https://hal.archives-ouvertes.fr/hal-03149196